Microsoft: Q3 Earnings Consensus Estimates

Microsoft (NASDAQ: MSFT) will be reporting their fiscal third quarter financials on April 27th after market close. Analysts have a consensus $276.31 12-month price target on the company, via a total of 38 analysts, with 17 analysts having strong buy ratings. 17 analysts meanwhile have buy ratings and four have hold ratings. The street high comes from PNP Paribas with a $330 price target, and the lowest target sits at $180.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $41 billion; this number has been revised upwards from $38.7 billion at the start of the year. The highest revenue estimate is $42 billion, while the lowest is $40.5 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have third-quarter EBITDA estimates. The mean is currently $19 billion, with this number having been revised down from $17.4 billion at the start of the year. Street high is $19.5 billion EBITDA estimate and the lowest is $18.3 billion.

Analysts estimate that quarterly earnings per share will come in at $1.82, with this number being revised upwards from $1.58 at the start of the year. Street high is $1.93 and the lowest estimate is $1.69 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

The Biggest Undeveloped Gold Project Still Needs One Thing | Rudi Fronk – Seabridge

The Silver Market May Be Closer to Breaking Than It Looks | Andy Schectman

Recommended

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Canadian Gold Resources Taps Chernin as Interim CEO in Planned Transition

Related News

BMO: Dollarama Is Resilient During Times Of High Inflation

On June 8, Dollarama Inc (TSX: DOL) reported its fiscal first-quarter financial results for 2023,...

Sunday, June 19, 2022, 03:03:00 PM

Medipharm Labs Sees Canaccord Drop Price Target To $0.75

On May 17th, MediPharm Labs (TSX: LABS) Labs reported their first-quarter financials. The company announced...

Tuesday, May 18, 2021, 05:32:00 PM

K92: BMO Trims 2022 Production Estimates After Q2 Results

K92 Mining Inc. (TSX: KNT) reported its second quarter production results last week. The company...

Monday, July 18, 2022, 11:30:50 AM

Curaleaf: The Analyst Take On The European Expansion

On April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of...

Friday, April 9, 2021, 11:46:00 AM

Cameco: Canaccord Refers To Firm As “Go-To” Name For Uranium Exposure

On February 9th, Cameco (TSX: CCO) reported its full-year 2021 financial results. The company reported...

Saturday, February 12, 2022, 02:03:00 PM